SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000947871-03-002481
Filing Date
2003-11-13
Accepted
2003-11-13 16:54:23
Documents
3
Group Members
ORBIMED ADVISORS LLCORBIMED CAPITAL LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G s13g_111303.txt SC 13G 7837
3 JOINT FILING AGREEMENT ex1-1_111303.txt EX-1.1 1973
4 STATEMENT OF CONTROL PERSON ex2-1_111303.txt EX-2.1 745
  Complete submission text file 0000947871-03-002481.txt   12929
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Subject) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-39976 | Film No.: 03998816
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 41 MADISON AVE 40TH FL NEW YORK NY 10010 2126845700
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE